FI922270L - Diltiazemiformulation - Google Patents

Diltiazemiformulation Download PDF

Info

Publication number
FI922270L
FI922270L FI922270A FI922270A FI922270L FI 922270 L FI922270 L FI 922270L FI 922270 A FI922270 A FI 922270A FI 922270 A FI922270 A FI 922270A FI 922270 L FI922270 L FI 922270L
Authority
FI
Finland
Prior art keywords
diltiazemi
formulation
diltiazemi formulation
Prior art date
Application number
FI922270A
Other languages
English (en)
Finnish (fi)
Other versions
FI922270A7 (fi
FI922270A0 (fi
Inventor
Dennis L Hendrickson
Dan C Dimmitt
Mark S Williams
Paul F Skultety
Michael J Baltezor
Original Assignee
Marion Merrell Dow Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marion Merrell Dow Inc filed Critical Marion Merrell Dow Inc
Publication of FI922270A0 publication Critical patent/FI922270A0/fi
Publication of FI922270A7 publication Critical patent/FI922270A7/fi
Publication of FI922270L publication Critical patent/FI922270L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
FI922270A 1991-05-20 1992-05-19 Diltiazemiformulation FI922270L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70256791A 1991-05-20 1991-05-20

Publications (3)

Publication Number Publication Date
FI922270A0 FI922270A0 (fi) 1992-05-19
FI922270A7 FI922270A7 (fi) 1992-11-21
FI922270L true FI922270L (fi) 1992-11-21

Family

ID=24821752

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922270A FI922270L (fi) 1991-05-20 1992-05-19 Diltiazemiformulation

Country Status (17)

Country Link
EP (1) EP0514814B1 (enExample)
JP (1) JP3804029B2 (enExample)
KR (1) KR100244010B1 (enExample)
AT (1) ATE147982T1 (enExample)
AU (1) AU653223B2 (enExample)
CA (1) CA2068980A1 (enExample)
DE (1) DE69216910T2 (enExample)
DK (1) DK0514814T3 (enExample)
ES (1) ES2099764T3 (enExample)
FI (1) FI922270L (enExample)
GR (1) GR3022927T3 (enExample)
IE (1) IE921603A1 (enExample)
IL (1) IL101896A (enExample)
NO (1) NO921973L (enExample)
NZ (1) NZ242730A (enExample)
TW (1) TW265267B (enExample)
ZA (1) ZA923474B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
ATE218869T1 (de) * 1993-09-08 2002-06-15 Pharmacy And Therapeutic Advis Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
DE69834195T2 (de) 1997-07-02 2007-03-29 Euro-Celtique S.A. Stabilisierte tramadol formulierungen mit verzögerter freisetzung
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
WO1999038507A1 (en) * 1998-01-30 1999-08-05 David George Le Couteur Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation
HU230454B1 (hu) * 1998-11-02 2016-07-28 Alkermes Pharma Ireland Limited Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény
AU2002256092C1 (en) * 2001-04-05 2009-10-15 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
WO2005051322A2 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
US7866376B2 (en) 2007-10-29 2011-01-11 Fu Zhun Precision Industry (Shen Zhen) Co., Ltd. Heat dissipation device with U-shaped and S-shaped heat pipes
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN114425046B (zh) * 2021-12-16 2023-10-20 南通联亚药业股份有限公司 一种盐酸地尔硫卓缓释胶囊

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
EP0225085A1 (en) * 1985-11-13 1987-06-10 ELAN CORPORATION, Plc Controlled absorption pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
EP0856313A1 (en) * 1987-10-16 1998-08-05 ELAN CORPORATION, Plc Controlled absorption diltiazem formulations
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
SE8902699D0 (sv) * 1989-08-09 1989-08-09 Lejus Medical Ab Diltiazem containing pharmaceutical compositios

Also Published As

Publication number Publication date
EP0514814A1 (en) 1992-11-25
CA2068980A1 (en) 1992-11-21
IL101896A0 (en) 1992-12-30
JP3804029B2 (ja) 2006-08-02
IL101896A (en) 1996-08-04
FI922270A7 (fi) 1992-11-21
JPH05178747A (ja) 1993-07-20
FI922270A0 (fi) 1992-05-19
NZ242730A (en) 1994-09-27
KR920021150A (ko) 1992-12-18
DK0514814T3 (da) 1997-02-10
EP0514814B1 (en) 1997-01-22
NO921973D0 (no) 1992-05-19
AU1632692A (en) 1992-11-26
ATE147982T1 (de) 1997-02-15
GR3022927T3 (en) 1997-06-30
KR100244010B1 (ko) 2000-03-02
ZA923474B (en) 1993-01-27
AU653223B2 (en) 1994-09-22
DE69216910T2 (de) 1997-05-22
DE69216910D1 (de) 1997-03-06
ES2099764T3 (es) 1997-06-01
TW265267B (enExample) 1995-12-11
NO921973L (no) 1992-11-23
IE921603A1 (en) 1992-12-02

Similar Documents

Publication Publication Date Title
FI933122L (fi) Foerbaettrad herbicidisk formulering
NO934009D0 (no) Farmasoeytiske formuleringer
FI921977A7 (fi) Vaotskivbroms
FI924967A0 (fi) Doerrhandtagskombination
FI924392L (fi) Blandning innehaollande farmaceutiskt felbinat
DE59209976D1 (de) Flaschendispenser
FI922270L (fi) Diltiazemiformulation
FI925120A7 (fi) Kopplingssystem foer ledningar
FI923868L (fi) Pastiller
FI924305L (fi) N-alkyl-3-fenyl-3-(2-alkyltiofenoxi)propylaminer
FI923429L (fi) Bigaggregat
FI924476L (fi) Smoerjmedel
FI924424L (fi) Hjaertskyddande tokoferolanaloger
FI924884L (fi) Loesningsmedelfri belaeggninskomposition
FI924701A0 (fi) Foertjockningsmedel
FI912920L (fi) Drumtvaettare
DE69126968D1 (de) Tamburin
FI921827A7 (fi) Provapparatur
FI924972A7 (fi) Elugn
FI934710A0 (fi) 4-aryl-3-(heteroarylureido)kinolinderivat
FI921876L (fi) Farmaceutisk komposition innehaollande diritromycin
MX9204183A (es) Formulacion de prostagladina e1
FI88477B (fi) Skrivare
FI923224A7 (fi) Oeppnande aendvaegg foer sluten dubbeldaeckad jaernvaegsgodsvagn
FI922069L (fi) Vaetedecykliseringsfoerfarande

Legal Events

Date Code Title Description
FD Application lapsed